Neurochemistry of Metabolic Diseases
Lysosomal Storage Diseases, Phenylketonuria & Canavan Disease
Seiten
2012
Nova Science Publishers Inc (Verlag)
978-1-61209-671-1 (ISBN)
Nova Science Publishers Inc (Verlag)
978-1-61209-671-1 (ISBN)
Metabolic disorder is caused by a gene defect, environmental factors or an unknown aetiology. Altered metabolism caused by these factors affects normal function of various organs including the brain and may lead to abnormal phenotype. This book reveals what factors contribute in lysosomal storage diseases, Phenylketonuria and Canavan disease.
Metabolic disorder is caused by a gene defect, environmental factors or an unknown aetiology. Altered metabolism caused by these factors affects normal function of various organs including the brain and may lead to abnormal phenotype. Understanding agents of causing these abnormalities is useful to interpret possible targets in these diseases. This book reveals what factors contribute in lysosomal storage diseases, Phenylketonuria and Canavan disease, as they are major emerging diseases in multiethnic populations.
Metabolic disorder is caused by a gene defect, environmental factors or an unknown aetiology. Altered metabolism caused by these factors affects normal function of various organs including the brain and may lead to abnormal phenotype. Understanding agents of causing these abnormalities is useful to interpret possible targets in these diseases. This book reveals what factors contribute in lysosomal storage diseases, Phenylketonuria and Canavan disease, as they are major emerging diseases in multiethnic populations.
Sialidosis: Pathophysiology & Therapeutic Approaches; Gaucher disease & therapeutic approaches; Parkinson's disease: molecular changes & therapeutic approaches; Ataxia-telangiectasia: Clinical symptoms & therapeutic approaches; Rett syndrome & therapeutic approaches; Krabbe Disease & therapeutical approaches; Gangliosidoses: molecular pathology & therapeutic approaches; Enzyme replacement therapy for lysosomal storage diseases; Cell-based Gene Therapy for Lysosomal Storage Diseases; Biomarkers for lysosomal storage disorders; PKU in Turkey: screening, diagnosis & management; Phenylketonuria & therapeutic approaches; Canavan disease: molecular pathology, phenotype & therapeutic approaches; Index.
Zusatzinfo | Illustrations |
---|---|
Verlagsort | New York |
Sprache | englisch |
Maße | 260 x 180 mm |
Gewicht | 732 g |
Themenwelt | Studium ► 1. Studienabschnitt (Vorklinik) ► Biochemie / Molekularbiologie |
ISBN-10 | 1-61209-671-9 / 1612096719 |
ISBN-13 | 978-1-61209-671-1 / 9781612096711 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich